Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2791519 | 0.76 | TSHR (0.47) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL235139 | 0.76 | MTNR1A (0.49) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL513073 | 0.76 | TDP1 (0.45) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL13559176 | 0.76 | ELANE (0.47) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL28081638 | 0.75 | THRB (0.51) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL16595000 | 0.75 | TDP1 (0.41) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL230778 | 0.75 | TDP1 (0.50) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL8899641 | 0.75 | TDP1 (0.50) | TDP1POLBAPEX1HTTTSHR | |
| SCHEMBL5724911 | 0.75 | HPGD (0.37) | TDP1TSHRMTNR1AMTNR1B | |
| SCHEMBL8899918 | 0.74 | TDP1 (0.49) | TDP1POLBAPEX1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090030093-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | BASF AKTIENGESSELLSCHAFT (DE) | 2009-01-29 | — | — | US | disclosed |
| US-7417098-B2 | Method for emulsion polymerisation of olefins | BASF SE (DE) | 2008-08-26 | — | — | US | disclosed |
| US-20080182915-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-31 | — | — | US | disclosed |
| US-20070043163-A1 | Method for emulsion polymerisation of olefins | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182915-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | SQLE, PHOSPHO1, ALOX15 | TDP1 3650/4885POLB 86/4885APEX1 832/4885 |
| US-20070043163-A1 | Method for emulsion polymerisation of olefins | PHOSPHO1, SQLE, ALOX15 | TDP1 4032/4885POLB 91/4885APEX1 974/4885 |
| US-20090030093-A1 | METHOD FOR EMULSION POLYMERISATION OF OLEFINS | PHOSPHO1, SQLE, ALOX15 | TDP1 4032/4885POLB 91/4885APEX1 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.